LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implentation of H.R. 3590 the Affordable Care Act; Implementation of H.R. 4872 The Health Care and Education Reconcilaition Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant the President - WH Leg Affairs |
Labor Issues/Antitrust/Workplace LBR
H.R. 1706 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of generic drugs in the market S. 369 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of generic drugs in the market
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Asst to the President - WH Leg Affairs |
Copyright/Patent/Trademark CPT
S. 515 - A bill to amend titl 35, United States Code, to provide Patent Reform S. 610 - A bill to amend title 35, United States Code, to provide for Patent Reform S. 3677 - FY 2011 Financial Services and General Government appropriations bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President - WH Leg Affair |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.